Recent advances in the design and applications of amyloid-β peptide aggregation inhibitors for Alzheimer's disease therapy

S Jokar, S Khazaei, H Behnammanesh, A Shamloo… - Biophysical …, 2019 - Springer
Alzheimer's disease (AD) is an irreversible neurological disorder that progresses gradually
and can cause severe cognitive and behavioral impairments. This disease is currently …

Engineering of structural and functional properties of nanotherapeutics and nanodiagnostics for intranasal brain targeting in Alzheimer's

NS Hinge, H Kathuria, MM Pandey - Applied Materials Today, 2022 - Elsevier
Alzheimer's disease (AD) is the fifth leading cause of death on the planet. It hallmarks the
presence of amyloid plaques and neurofibrillary tangles in geriatric patients. The condition …

Peptide‐Functionalized Prussian Blue Nanomaterial for Antioxidant Stress and NIR Photothermal Therapy against Alzheimer's Disease

X Song, Q Ding, W Wei, J Zhang, R Sun, L Yin, S Liu… - Small, 2023 - Wiley Online Library
Excessive accumulations of reactive oxygen species (ROS) and amyloid‐β (Aβ) protein are
closely associated with the complex pathogenesis of Alzheimer's disease (AD). Therefore …

Probing Interfacial Charge Transfer between Amyloid-β and Graphene during Amyloid Fibrillization Using Raman Spectroscopy

W Cha, C Heo, S Lee, SJ Yun, BW Cho, T Ha, YH Lee - ACS nano, 2023 - ACS Publications
Charge transfer plays a key role in the structural transformation of amyloid-β proteins (Aβs),
as it fibrillizes from small monomers to intermediate oligomers and to ordered fibrils. While …

In Vivo and In Vitro Monitoring of Amyloid Aggregation via BSA@FGQDs Multimodal Probe

M Yousaf, M Ahmad, IA Bhatti, A Nasir, M Hasan… - ACS …, 2018 - ACS Publications
Early detection of peptide aggregate intermediates is quite challenging because of their
variable and complex nature as well as due to lack of reliable sensors for diagnosis. Herein …

Mitigating human IAPP amyloidogenesis in vivo with chiral silica nanoribbons

A Faridi, Y Sun, Y Okazaki, G Peng, J Gao, A Kakinen… - Small, 2018 - Wiley Online Library
Amyloid fibrils generally display chirality, a feature which has rarely been exploited in the
development of therapeutics against amyloid diseases. This study reports, for the first time …

Nanodisc-forming scaffold protein promoted retardation of amyloid-beta aggregation

BR Sahoo, T Genjo, SJ Cox, AK Stoddard… - Journal of molecular …, 2018 - Elsevier
Peptidic nanodiscs are useful membrane mimetic tools for structural and functional studies
of membrane proteins, and membrane interacting peptides including amyloids. Here, we …

Liquid–liquid phase separation (llps)-driven fibrilization of amyloid-β protein

S Sudhakar, A Manohar, E Mani - ACS Chemical Neuroscience, 2023 - ACS Publications
Amyloid-β [Aβ (1–40)] aggregation into a fibrillar network is one of the major hallmarks of
Alzheimer's disease (AD). Recently, a few studies reported that polyphosphate (polyP), an …

Nanochaperone‐Based Strategies to Control Protein Aggregation Linked to Conformational Diseases

AB Caballero, P Gamez - Angewandte Chemie, 2021 - Wiley Online Library
The generation of highly organized amyloid fibrils is associated with a wide range of
conformational pathologies, including primarily neurodegenerative diseases. Such …

Charge effects of self-assembled chitosan-hyaluronic acid nanoparticles on inhibiting amyloid β-protein aggregation

Z Jiang, X Dong, Y Sun - Carbohydrate research, 2018 - Elsevier
Amyloid β-protein (Aβ) aggregation is crucial for the pathogenesis of Alzheimer's disease,
and surface charge of nanoparticles (NPs) has been recognized as an important factor …